Papers
2
Total Citations
22
H-Index
2
About
Helen Parsons is a leading clinical trialist whose work is reshaping the evidence base for orthopaedic surgery, with a specific focus on robotic-assisted joint replacement. Her primary research areas include the clinical and cost-effectiveness of surgical technologies, randomised controlled trial methodology, and health economics in orthopaedics. Parsons is best known for leading the landmark RACER programme, which includes the RACER-knee and RACER-Hip trials—among the first large-scale, multicentre randomised controlled trials to rigorously evaluate robotic-arm systems against conventional total knee and hip arthroplasty. Her 2023 protocol papers (17 and 5 citations, respectively) have become foundational references, establishing a gold-standard framework for assessing whether these expensive technologies truly improve patient outcomes and offer value for money. By designing trials that integrate clinical outcomes with health economic analysis, Parsons has directly addressed the critical gap between technological promise and real-world evidence. Her work is instrumental in guiding policy decisions for the UK’s National Health Service, ensuring that surgical innovation is matched by robust, patient-centred data. For students and researchers, Parsons exemplifies how rigorous trial design can transform surgical practice and healthcare resource allocation.
Research Focus
Key Achievements
Top Papers
- 1
- 2